249 related articles for article (PubMed ID: 28869448)
21. Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145.
Zhou X; Gao Q; Wang J; Zhang X; Liu K; Duan Z
Gynecol Oncol; 2014 May; 133(2):333-9. PubMed ID: 24589415
[TBL] [Abstract][Full Text] [Related]
22. Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer.
Li L; Zhang GQ; Chen H; Zhao ZJ; Chen HZ; Liu H; Wang G; Jia YH; Pan SH; Kong R; Wang YW; Sun B
Oncotarget; 2016 Nov; 7(44):71773-71781. PubMed ID: 27708234
[TBL] [Abstract][Full Text] [Related]
23. Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells.
Chen YM; Liu Y; Wei HY; Lv KZ; Fu PF
Oncotarget; 2016 Sep; 7(37):59604-59617. PubMed ID: 27449099
[TBL] [Abstract][Full Text] [Related]
24. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
[TBL] [Abstract][Full Text] [Related]
25. Functional Variants in Linc-ROR are Associated with mRNA Expression of Linc-ROR and Breast Cancer Susceptibility.
Luo C; Cao J; Peng R; Guo Q; Ye H; Wang P; Wang K; Song C
Sci Rep; 2018 Mar; 8(1):4680. PubMed ID: 29549263
[TBL] [Abstract][Full Text] [Related]
26. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
[TBL] [Abstract][Full Text] [Related]
27. [
Li X; Li N
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 50(2):177-181. PubMed ID: 31106535
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of long non-coding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer.
Li Y; Jiang B; Zhu H; Qu X; Zhao L; Tan Y; Jiang Y; Liao M; Wu X
Tumour Biol; 2017 Jun; 39(6):1010428317705790. PubMed ID: 28635401
[TBL] [Abstract][Full Text] [Related]
29. Plasma cell-free DNA integrity plus circulating tumor cells: a potential biomarker of no distant metastasis breast cancer.
Wang W; Liang M; Ma G; Li L; Zhou W; Xia T; Xie H; Wang S
Neoplasma; 2017; 64(4):611-618. PubMed ID: 28485169
[TBL] [Abstract][Full Text] [Related]
30. Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer.
Zidan HE; Karam RA; El-Seifi OS; Abd Elrahman TM
Cancer Genet; 2018 Jan; 220():32-37. PubMed ID: 29310836
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study.
Xu N; Chen F; Wang F; Lu X; Wang X; Lv M; Lu C
Tumour Biol; 2015 Sep; 36(10):7659-65. PubMed ID: 25929808
[TBL] [Abstract][Full Text] [Related]
32. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker.
Tan Q; Zuo J; Qiu S; Yu Y; Zhou H; Li N; Wang H; Liang C; Yu M; Tu J
Int J Oncol; 2017 May; 50(5):1729-1738. PubMed ID: 28339045
[TBL] [Abstract][Full Text] [Related]
33. Linc-ROR induces epithelial-to-mesenchymal transition in ovarian cancer by increasing Wnt/β-catenin signaling.
Lou Y; Jiang H; Cui Z; Wang L; Wang X; Tian T
Oncotarget; 2017 Sep; 8(41):69983-69994. PubMed ID: 29050257
[TBL] [Abstract][Full Text] [Related]
34. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
35. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer.
Zhou X; Yin C; Dang Y; Ye F; Zhang G
Sci Rep; 2015 Jun; 5():11516. PubMed ID: 26096073
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.
Gao J; Cao R; Mu H
Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487
[TBL] [Abstract][Full Text] [Related]
37. Synergistic anticancer effects of co-delivery of linc-RoR siRNA and curcumin using polyamidoamine dendrimers against breast cancer.
Vahedi F; Javan B; Sharbatkhari M; Soltani A; Shafiee M; Memarian A; Erfani-Moghadam V
Biochem Biophys Res Commun; 2024 Apr; 705():149729. PubMed ID: 38452515
[TBL] [Abstract][Full Text] [Related]
38. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar NI; Gaefar HA
Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
[TBL] [Abstract][Full Text] [Related]
39. linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer.
He W; Cai Q; Sun F; Zhong G; Wang P; Liu H; Luo J; Yu H; Huang J; Lin T
Biochim Biophys Acta; 2013 Oct; 1832(10):1528-37. PubMed ID: 23688781
[TBL] [Abstract][Full Text] [Related]
40. The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers.
Pan Y; Li C; Chen J; Zhang K; Chu X; Wang R; Chen L
Cell Physiol Biochem; 2016; 40(1-2):219-229. PubMed ID: 27855392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
